Polymorphic light eruption

Dermatologic Therapy

Volumn 16, Issue 1, 2003, Pages 28-39

  Tutrone, William D ^a   Spann, Candace Thornton ^a   Scheinfeld, Noah ^a   Deleo, Vincent A ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

Abnormal arachidonic acid metabolism; Delayed type hypersensitivity reaction; Drug therapy; Photosensitivity; PUVA therapy; SLE overlap; UVB (TL 01) therapy

Indexed keywords

ANTIMALARIAL AGENT; BETA CAROTENE; CANTHAXANTHIN; CAROTENOID; CHLOROQUINE; CORTICOSTEROID; HYDROXYCHLOROQUINE; METHOXSALEN; NICOTINAMIDE;

ADULT; AGED; ARACHIDONIC ACID METABOLISM; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSSOVER PROCEDURE; DELAYED HYPERSENSITIVITY; DRUG EFFICACY; ERYTHEMA; EYE TOXICITY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHOTODERMATOSIS; PHOTOTHERAPY; POLYMORPHIC LIGHT ERUPTION; PRURITUS; PUVA; REVIEW; SKIN MANIFESTATION;

ARACHIDONIC ACID; COMORBIDITY; DERMATOLOGIC AGENTS; HUMANS; HYDROXYCHLOROQUINE; LUPUS ERYTHEMATOSUS, SYSTEMIC; NIACINAMIDE; PHOTOSENSITIVITY DISORDERS; PUVA THERAPY; SUNSCREENING AGENTS; TREATMENT OUTCOME;

EID: 0038624554     PISSN: 13960296     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1529-8019.2003.01605.x     Document Type: Review

References (60)

1. Frain-Bell W. The idiopathic photodermatoses. In: Cutaneous photobiology. Oxford: Oxford University Press, 1985: 24-38.
2. Jansen CT. The natural history of polymorphous light eruptions. Arch Dermatol 1979: 115: 165.
3. Morrison WL, Stern RS. Polymorphous light eruption: a common reaction uncommonly recognized. Acta Derm Venereol (Stockh) 1982: 62: 237.
4. Hawk JLM, Norris PG. Abnormal responses to ultraviolet radiation: idiopathic. In: Fitzpatrick's dermatology in general medicine, 5th ed. New York: McGraw-Hill, 1999: 1573-1589.
5. Ros A, Wennersten G. Current aspects of polymorphous light eruption in Sweden. Photodermatology 1986: 3: 298.
6. Pao C, Norris PG, Corbett M, et al. Polymorphic light eruption: prevalence in Australia and England. Br J Dermatol 1994: 130: 62.
7. Baadsgaard O, Cooper KD, Lisby S, et al. Dose response and time course for induction of T6-DR+ human epidermal antigen-presenting cells by in vivo ultraviolet A, B, and C irradiation. J Am Acad Dermatol 1987: 17: 92.
8. Millard TP, Bataille V, Sneider H, Spector TD, McGregor JM. The heritability of polymorphic light eruption. J Invest Dermatol 2000: 115: 467-470.
9. Farr PM, Diffey BL. Effect of indomethacin on UVB- and UVA-induced erythema in polymorphic light eruption. J Am Acad Dermatol 1989: 21: 230-236.
10. Hönigsmann H. Polymorphous light eruption. In: Lim HW, Soter NA, eds. Clinical photomedicine. New York: Marcel Dekker, 1993: 167-180.
11. Jansen C. β-carotene treatment of polymorphous light eruption. Dermatologica 1974: 149: 363-373.
12. Kontos A, Cusack C, Lim HW. Polymorphous light eruption (PMLE) in African-Americans presenting as pinpoint papules. Photodermatol Photoimmunol Photomed 2002: 18: 105.
13. Velthuis PJ, Van Weelden H, Van Wichen D, De La Faille HB. Immunohistopathology of light-induced skin lesions in lupus erythematosus. Acta DermVenereol (Stockh) 1990: 70: 93-98.
14. Muhlbauer JE, Bhan AK, Harrist THJ, Bernhard JD, Mihm MC. Papular polymorphic light eruption and immunoperoxidase study using monoclonal antibodies. Br J Dermatol 1983: 108: 153-162.
15. Ralfkiaer E, Lange Wantzin G. In situ immunological characterization of infiltrating cells in positive patch test. Br J Dermatol 1984: 111: 13-32.
16. Muhlbauer JE, Mihm MC, Harrist TJ. Papular polymorphous light eruption. Arch Dermatol 1984: 120: 866-868.
17. Nieboer C. Immunofluorescence patterns in sun-exposed and not-sunexposed skin in healthy individuals. Acta Derm Venereol (Stockh) 1981: 61: 471-479.
18. Baart de la Faille-Kuyper EH, Cormane RH. The occurrence of certain serum factors in the dermal-epidermal junction and vessel walls of the skin in lupus erythematosus and other (skin) disease. Acta Derm Venereol (Stockh) 1968: 48: 578-588.
19. Murphy GM, Hawk JLM. The prevalence of antinuclear antibodies in patients with apparent polymorphic light eruption. Br J Dermatol 1991: 125: 448-451.
20. Millard TP, Kondeatis E, Cox A, et al. A candidate gene analysis of three related photosensitivity disorders: cutaneous lupus erythematosus, polymorphic light eruption and actinic prurigo. Br J Dermatol 2001: 145: 229-236.
21. Millard TP, Lewis CM, Khamashta MA, Hughes GRV, Hawk JLM, McGregor JM. Familial clustering of polymorphic light eruption in relatives of patients with lupus erythematosus: evidence of a shared pathogenesis. Br J Dermatol 2001: 144: 334-338.
22. Hasan T, Ranki A, Jansen CT, Karvonen J. Disease associations in polymorphous light eruption. A long-term follow-up study of 94 patients. Arch Dermatol 1998: 134: 1081-1085.
23. Nyberg F, Hasan T, Puska P, et al. Occurrence of polymorphous light eruption in lupus erythematosus. Br J Dermatol 1997: 136: 217-221.
24. Wechsler HL. Cutaneous disease in systemic lupus erythematosus. Clin Dermatol 1985: 3: 79-87.
25. Holzle E, Plewig G, Hofmann C, et al. Polymorphous light eruption: experimental reproduction of skin lesions. J Am Acad Dermatol 1982: 7: 111.
26. Ortel B, Tanew A, Wolff K, et al. Polymorphous light eruption: action spectrum and photoprotection. J Am Acad Dermatol 1986: 14: 748.
27. Miyamoto C. Polymorphous light eruption: successful reproduction of skin lesions, including papulovesicular light eruption, with ultraviolet B. Photodermatology 1989: 6: 69-79.
28. Przybilla B, Galosi A, Heppeler M, et al. Polymorphous light eruption: eliciting and inhibiting wavelengths. Acta Derm Venereol (Stockh) 1988: 68: 173-176.
29. Norris PG, Hawk JL. Polymorphic light eruption. Photodermatol Photoimmunol Photomed 1990: 7: 186-191.
30. Verheyen AMF, Lambert JRMG, Van Marck EAE, Dockx PFE. Polymorphic light eruption - an immunopathological study of provoked lesions. Clin Exp Dermatol 1995: 20: 297-303.
31. Snyder DS, Eaglstein WH. Topical indomethacin and sunburn. Br J Dermatol 1974: 90: 91-93.
32. Farr PM, Diffey BL. A quantitative study of the effect of topical indomethacin on cutaneous erythema induced by UVB and UVC radiation. Br J Dermatol 1986: 115: 453-466.
33. Farr PM, Diffey BL. Augmentation of ultraviolet erythema by indomethacin in actinic prurigo - evidence of mechanism of photosensitivity. Photochem Photobiol 1988: 47: 413-417.
34. Morrison WL, Paul BS, Parrish JA. The effects of indomethacin on long-wave ultraviolet-induced delayed erythema. J Invest Dermatol 1977: 68: 130-133.
35. Bray MA, Morley J, eds. The pharmacology of lymphocytes. New York: Springer-Verlag, 1988.
36. Stobo JD, Kennedy MS, Goldyne MF. Prostaglandin E modulation of the mitogenic response of human T cells. J Clin Invest 1979: 64: 1188-1203.
37. June B-D, Roberts LK, Cho B-H, Robertson B, Daynes RA. Parallel recovery of epidermal antigen-presenting cell activity and contact hypersensitivity responses in mice exposed to ultraviolet irradiation: the role of a prostaglandin-dependent mechanism. J Invest Dermatol 1988: 90: 311-316.
38. Fulton AM, Long JG. The induction of non-specific T suppressor lymphocytes byprostaglandin E. Cell Immunol 1981: 59: 54-60.
39. Man I, Dawe S, Ferguson J. Artificial hardening for polymorphic light eruption: practical points from ten years' experience. Photodermatol Photoimmunol Photomed 1999: 15(3-4): 96-99.
40. Addo HA, Sharma SC. UVB phototherapy and photochemotherapy (PUVA) in the treatment of polymorphic light eruption and solar urticaria. Br J Dermatol 1987: 116: 539-547.
41. Murphy GM, Logan RA, Lovell CR, Morris RW, Hawk JLM, Magnus IA. Prophylactic PUVA and UVB therapy in polymorphic light eruption - a controlled trial. Br J Dermatol 1987: 116: 531-538.
42. Bilsland D, George SA, Gibbs NK, Aitchison T, Johnson BE, Ferguson J. A comparison of narrow band phototherapy (TL-01) and photochemotherapy (PUVA) in the management of polymorphic light eruption. Br J Dermatol 1993: 129: 708-712.
43. deGruijl FR. Long-term side effects and carcinogenesis risk in UVB therapy. In: Honigsmann H, Jori G, Young AR, eds. The fundamental bases of phototherapy. Milan, Italy: OEMF, 1996: 153-170.
44. Cahn MM, Levy EJ, Shaffer B. The use of chloroquine diphosphate (Aralen) and quinacrine (Atabrine) hydrochloride in the prevention of polymorphous light eruption. J Invest Dermatol 1954: 22: 93.
45. Christiansen JV, Brodthagen H. The treatment of polymorphic light eruption with chloroquine. Br J Dermatol 1956: 68: 204.
46. Woodburne AR, Philpott OS, Philpott JA. Quinacrine (Atabrine) in treatment of solar dermatoses. Arch Dermatol 1964: 70: 116.
47. Corbett MF, Davis JL, Hawk JLM. Controlled clinical trials of treatments for skin photosensitivity. Statistician 1981: 31: 53.
48. Rynes RI, Krohel G, Falbo A. Ophthalmologic safety of long-term hydroxychloroquine treatment. Arthritis Rheum 1979: 22: 832.
49. Tobin DR, Krohel GB, Rynes RI. Hydroxychloroquine: seven-year experience. Arch Ophthalmol 1982: 100: 81.
50. Murphy GE, Hawk JLM, Magnus IA. Hydroxychloroquine in polymorphic light eruption: a controlled trial with drug and visual sensitivity monitoring. Br J Dermatol 1987: 116: 379-386.
51. World Health Organization. Information on malaria risk for international travelers. Week Epidemiol Rec 1976: 51: 181.
52. Wennersten G. Carotenoid treatment for light sensitivity: a re-appraisal after 6 years experience. Arch Dermatol 1980: 60: 251.
53. Swanbeck G, Wennersten G. Treatment of polymorphic light eruption with beta-carotene. Arch Dermatol 1972: 52: 462.
54. Goertz G, Ippen H. Carotene-Behandling von Lichtdermatosen. Dtsch Med Wochenschr 1977: 102: 1051.
55. Nordlund JJ, Klaus SN, Mathews-Roth MM, Pathak MA. New therapy for polymorphous light eruption. Arch Dermatol 1973: 108: 710.
56. Wennersten G, Swanbeck G. Treatment of light sensitivity with carotenoids. Arch Dermatol 1974: 54: 491.
57. Haeger-Aronsen B, Krook G, Abdulla M. Oral carotenoids for photohypersensitivity in patients with erythrohepatic protoporphyria, polymorphous light eruptions and lupus erythematodes discoides. Int J Dermatol 1979: 18: 73.
58. Neumann R, Rappold E, Pohl-Markl H. Treatment of polymorphous light eruption with nicotinamide: a pilot study. Br J Dermatol 1986: 115: 77-80.
59. Ortel B, Wechdorn D, Tanew A, et al. Effect of nicotinamide on the phototest reaction in polymorphous light eruption. Br J Dermatol 1988: 118: 669-673.
60. Rasch C. Om et polymorft (erytematost, vesikulost og ekzematoïct) Lysudslet. Dansk dermatologisk selskab. Ilte Mode, Onsdag Den 4de April, 1900. Hospitalstidende 1900: 43: 478-480.